Peter Ferrazzano, MD, has been named as one of the 2009 UW Institute for Clinical and Translational Research (ICTR) KL2 scholars. This award provides funding for 75% protected time for a minimum of two years.
Peter Ferrazzano, MD, has been named as one of the 2009 UW Institute for Clinical and Translational Research (ICTR) KL2 scholars. This award provides funding for 75% protected time for a minimum of two years.